Recovery from major depression is not associated with normalization of serotonergic function

Biological Psychiatry

Volumn 43, Issue 5, 1998, Pages 320-326

  Flory, Janine Dyck ^a,c   Mann, J John ^b   Manuck, Stephen B ^a   Muldoon, Matthew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Depression; Fenfluramine; History of depression; Serotonin

Indexed keywords

FENFLURAMINE; PROLACTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROVOCATION TEST; SEROTONINERGIC SYSTEM;

ADULT; DEPRESSIVE DISORDER; FEMALE; FENFLURAMINE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS;

EID: 0032030548     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00480-0     Document Type: Article

References (36)

1. Asnis GM, Eisenberg J, van Praag HM, Lemus CZ, Friedman JMH, Miller AH. The neuroendocrine response to fenfluramine in depressives and normal controls. Biol Psychiatry. 24:1988;117-120.
2. Coccaro EF, Murphy DL. Serotonin in Major Psychiatric Disorders. 1990;American Psychiatric Press, Washington, DC.
3. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry. 46:1989;587-599.
4. Fuller RW, Snoddy HD, Robertson DW. Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats Uptake inhibition versus release . Pharmacol Biochem Behav. 30:1988;715-721.
5. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry. 37:1995;434-441.
6. Harris T, Brown GW, Bifulco A. Loss of parent in childhood and adult psychiatric disorder A tentative overall model . Dev Psychopathol. 2:1990;311-328.
7. Higley JD, Suomi SJ, Linnoila M. CSF monoamine metabolite concentrations vary according to age rearing and sex and are influenced by the stressor of social separation in rhesus monkeys. Psychopharmacology (Berl). 103:1991;551-556.
8. Higley JD, Thompson WW, Champoux M, Goldman D, Hasert M, Kraemer GW, et al. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Arch Gen Psychiatry. 50:1993;615-623.
9. Kasper S, Vieira A, Schmidt R, Richter P. Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressant treatment. Pharmacopsychiatry. 23:1990;76-84.
10. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. A population-based twin study of major depression in women. Arch Gen Psychiatry. 49:1992;257-266.
11. Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Heath AC, et al. Stressful life events, genetic liability, and onset of major depression in women. Am J Psychiatry. 152:1995;833-842.
12. Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, et al. Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Res. 43:1992;137-146.
13. Maes M, Meltzer HY. The serotonin hypothesis of major depression. Bloom FE, Kupfer DJ. Psychopharmacology The Fourth Generation of Progress . 1995;933-944 Raven Press, New York.
14. Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J. HPA-axis hormones and prolactin response to dextro-fenfluramine in depressed patients and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry. 15:1991;781-790.
15. Mann JJ, Stanley M. Psychobiology of Suicidal Behavior. 1986;New York Academy of Sciences, New York.
16. Mann JJ, McBride A, Brown RP, Linnoila M, Leon AC, DeMeo MD, et al. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry. 49:1992;442-446.
17. Mann JJ, McBride A, Malone KM, DeMeo M, Kelip J. Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology. 13:1995;53-64.
18. McBride PA, Tierney H, DeMeo M, Chen J-S, Mann JJ. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry. 27:1990;1143-1155.
19. McGuffin P, Katz R, Watkins S, Rutherford J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch Gen Psychiatry. 53:1996;129-136.
20. Meaney MJ, Mitchell JB, Aitken DH, Bhatnagar S, Bodnoff SR, Iny LJ, et al. The effects of neonatal handling on the development of the adrenocortical response to stress Implications for neuropathology and cognitive deficits in later life . Psychoneuroendocrinology. 16:1991;85-103.
21. Mitchell P, Smythe G. Hormonal responses to fenfluramine in depressed and control subjects. J Affect Disord. 19:1990;43-51.
22. Mitchell JB, Iny LJ, Meaney MJ. The role of serotonin in the development and environmental regulation of type II corticosteroid receptor binding in rat hippocampus. Dev Brain Res. 55:1990a;231-235.
23. Mitchell JB, Rowe W, Boksa P, Meaney MJ. Serotonin regulates type II corticosteroid receptor binding in hippocampal cell cultures. J Neurosci. 10:1990b;1745-1752.
24. Muldoon MF, Manuck SB, Jansma CL, Moore AL, Perel J, Mann JJ. DL-Fenfluramine challenge test Experience in a nonpatient sample . Biol Psychiatry. 38:1996;761-768.
25. Murphy DL, Mellow AM, Sunderland T, Aulakh CS, Lawlor BL, Zohar J. Strategies for the study of serotonin in humans. Coccaro EF, Murphy DL. Serotonin in Major Psychiatric Disorders. 1990;3-25 American Psychiatric Press, Washington, DC.
26. O'Keane V, Dinan TG. Prolactin and cortisol responses to d-fenfluramine in major depression Evidence for diminished responsivity of central serotonergic function . Am J Psychiatry. 148:1991;1009-1015.
27. O'Keane V, McLoughlin D, Dinan TG. D-Fenfluramine-induced prolactin and cortisol release in major depression Response to treatment . J Affect Disord. 26:1992;143-150.
28. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - A genetic study. J Psychiatr Res. 20:1986;19-29.
29. Quattrone A, Tedeschi G, Aguglia U, Scopacasa F, DiRenzo GF, Annunziato L. Prolactin secretion in man, a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurons Studies with fenfluramine . Br J Pharmacology. 16:1983;471-475.
30. Shapira B, Cohen J, Newman ME, Lerer B. Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients. Biol Psychiatry. 33:1993;531-535.
31. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls An evaluation of central serotonergic responsivity in depression . Life Sci. 34:1984;1029-1039.
32. Smythe JW, Rowe WB, Meaney MJ. Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions Relationship to the handling effect on glucocorticoid receptor expression . Brain Res Dev Brain Res. 80:1994;183-189.
33. Spitzer RL, Williams JBW, Gibbon M, First MB (1990): Structured Clinical Interview for DSM-III-R: Non-Patient Edition (SCID-NP Version 1.0). Washington, DC: American Psychiatric Press.
34. Targum SD. Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biol Psychiatry. 28:1990;21-34.
35. Tennant C. Parental loss in childhood Its effect in adult life . Arch Gen Psychiatry. 45:1988;1045-1050.
36. Weizman A, Mark M, Gil-Ad I, Tyano S, Laron Z. Plasma cortisol, prolactin, growth hormone, and immunoreactive β-endorphin response to fenfluramine challenge in depressed patients. Clin Neuropharmacol. 11:1988;250-256.